Article

Chase finalizes Unicorn deal, expands line

Chase Card Services, a division of JPMorgan Chase & Co., has finalized the acquisition of Unicorn Financial Services, a financing company for health-care patients.

Wilmington, DE-Chase Card Services, a division of JPMorgan Chase & Co., has finalized the acquisition of Unicorn Financial Services, a financing company for health-care patients. The combined company officially has launched its expanded set of patient financing products as ChaseHealthAdvance financing options.

Increasing medical and dental costs have created a need for new and adaptive health-care financing options, according to the company. In addition, the demand for elective procedures-dental, vision correction, and cosmetic, as well as veterinary care for pets-is increasing rapidly.

"Chase is able to offer affordable, flexible options for those looking to finance health-care procedures, as well as provide competitive service fees for providers," said Hugh Bleemer, general manager, ChaseHealthAdvance.

For more information on Chase-HealthAdvance financing options, visit http://www.chasehealthadvance.com/.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.